Drugs / CDSR
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT04282044 Background | Jan 2021 → Aug 2025 overdue | colorectal cancer, gastric cancer, hepatocellular carcinoma, malignant epithelial tumor of ovary +4 | BioEclipse Therapeutics | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CDSR | “A fixed dose of CIK cells combined with the specified dose of CDSR.” NCT04282044 ↗ |